Linda Sharon Daintree

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Anavex Life Sciences Corp., Crystec Ltd, Changzhou Pharmaceutical Factory Co., Ltd.. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda Sharon Daintree. Retrieved from https://idiyas.com/inventor/linda-sharon-daintree

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

West Yorkshire, GB (2008)
Bradford, GB (2019)
Leeds, GB (2019 - 2023)

Company Filing History:

4 out of 33

Anavex Life Sciences Corp.

Changzhou Pharmaceutical Factory Co., Ltd.

patent

4. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12759986 - Crystal forms of tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine, processes of making such forms, and their pharmaceutical compositions (2026-10-13),

2. 11759420 - Inhalable particles (2023-09-19),

3. 11661405 - Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions (2023-05-30),

4. 11351115 - Inhalable particles (2022-06-07),

5. 10966952 - Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions (2021-04-06),

6. 10413519 - Crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions (2019-09-17),

7. 10258574 - Method of preparing itraconazole preparation (2019-04-16),

8. 7354601 - Particulate materials (2008-04-08),

Title: Innovations of Linda Sharon Daintree

Introduction

Linda Sharon Daintree is a prominent inventor based in Leeds, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations and compositions. With a total of seven patents to her name, Daintree's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Daintree's latest patents include a formulation of inhalable particles, which consists of a powder formulation comprising particles of an antimuscarinic agent. These particles are obtainable by supercritical anti-solvent (SAS) precipitation and have specific size characteristics. Additionally, she has developed crystal forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, which are characterized and disclosed in her patents. These polymorphic forms and their metabolites are aimed at treating Alzheimer's disease, showcasing her commitment to addressing critical health issues.

Career Highlights

Throughout her career, Daintree has worked with notable companies such as Crystec Ltd and Anavex Life Sciences Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Daintree has collaborated with esteemed colleagues, including Daniel Mark Ledger and Peter York. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of her inventions.

Conclusion

Linda Sharon Daintree's innovative work in pharmaceuticals exemplifies her dedication to improving healthcare through her inventions. Her patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.

Profile summary based on public USPTO records.